The transition towards targeted medicine has fundamentally altered how healthcare institutions approach blood component separation and analysis. At the center of this transformation is the Leukapheresis Products Market, which continues to expand as clinical workflows prioritize precise, uncompromised cellular isolation. Medical professionals rely on these advanced setups to secure specific...